Interpretative considerations for clinical pathology findings in nonclinical toxicology studies-Reference-Cited by-同舟云学术

Interpretative considerations for clinical pathology findings in nonclinical toxicology studies

Published:2019-09 Issue:3 Volume:48 Page:383-388
ISSN:0275-6382
Container-title:Veterinary Clinical Pathology
language:en
Short-container-title:Vet Clin Pathol

Author:

Aulbach Adam¹,Vitsky Allison²,Arndt Tara³,Ramaiah Lila⁴,Logan Michael⁵,Siska William⁶,Cregar Laura¹,Tripathi Niraj³,Adedeji Adeyemi⁷,Provencher Anne⁸,Gupta Ara⁹,Jordan Holly³,Bounous Denise¹⁰,Boone Laura³

Affiliation:

1. Charles River Laboratories Mattawan MI USA

2. Pfizer Inc. San Diego CA USA

3. Covance Laboratories Inc. Madison WI USA

4. Bristol‐Myers Squibb New Brunswick NJ USA

5. AbbVie Chicago IL USA

6. Charles River Laboratories, Inc. Reno NV USA

7. Genentech Inc San Francisco CA USA

8. Charles River Laboratories Senneville Quebec Canada

9. Boehringer Ingelheim Animal Health USA Inc. Duluth GA USA

10. Bristol‐Myers Squibb Lawrenceville NJ USA

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vcp.12773

Reference15 articles.

1. Principles for Assessing Adversity in Toxicologic Clinical Pathology

2. Reporting of clinical pathology interpretations in nonclinical toxicology studies: points to consider I;Aulbach A;Vet Clin Pathol

3. Scientific and Regulatory Policy Committee

4. Practical Considerations in Clinical Pathology Data Interpretation and Description

5. Lies, Damn Lies, and Reference Intervals (or Hysterical Control Values for Clinical Pathology Data)

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Considerations for the Identification and Conveyance of Clinical Pathology Findings in Preclinical Toxicity Studies: Results From the 9th ESTP International Expert Workshop;Toxicologic Pathology;2024-04-25

2. Liver and Gall Bladder;Haschek and Rousseaux' s Handbook of Toxicologic Pathology;2024

3. Clinical Pathology in Nonclinical Toxicity Studies;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024

4. Use of the dTAG system in vivo to degrade CDK2 and CDK5 in adult mice and explore potential safety liabilities;Toxicological Sciences;2023-05-25

5. Interpretation of Clinical Pathology Results in Nonclinical Toxicity Testing;Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology;2023